Like the phenotype in hypoxic conditions, RCC cells exhibited a DAC-resistant phenotype after DMOG treatment, comprising decreased ENT1 expression, reduced DAC and ETV uptake, and suppressed induction of OCT2 by DAC (Figure S6A-D). This evidence concerns the gene SLC29A1 and renal cell carcinoma.